ArticleMenopause (New York, N.Y.)2026
Prospective study of reproductive span and menopausal hormone therapy and cognitive decline over 8 years in the Nurses' Health Study.
Article in Menopause (New York, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
objectivesHigher endogenous estrogen may be associated with better cognition, but associations with menopausal hormone therapy (MHT) have been inconsistent, possibly due to differences in the timing of use. This prospective cohort study aimed to evaluate the associations between reproductive span, as a proxy for endogenous estrogen history, MHT use, and cognitive function.
methodsWe assessed cognitive change (1995-2008) with four telephone interviews (primary outcome: global composite score average of six test z -scores) in 14,217 Nurses' Health Study participants (mean age 74.3 y) and examined associations with reproductive span ([age at menopause]-[age at menarche]), and MHT use duration, separately by 0-10 years, and 11+ years after menopause.
resultsA longer reproductive span was associated with better cognitive trajectories (mean annual rate of change difference [95% CI] 41-46 vs. ≤33 y =0.008 [0.00005, 0.015]; P -trend=0.02). MHT use 0-10 years postmenopause was associated with faster decline (mean difference 8-10 vs. 0 y =-0.007 [-0.016, 0.002]; P -trend=0.02); use during 11+ years postmenopause was not associated.
conclusionsAlthough MHT use was not inversely associated, a longer reproductive span was associated with better cognitive trajectories.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.